Search
AI-Powered Medical Productivity Tool Developer 'Zero Hypothesis' Raises Nearly RMB 100 Million in Series A Funding
2025-10-30 /
Read about 0 minute
Author：小编
36Kr brings you an exclusive scoop: The AI-driven medical productivity tool developer 'Zero Hypothesis' has recently concluded a Series A funding round, amassing nearly RMB 100 million. The investor lineup features Hetang Venture Capital, Guofang Innovation, and Shanghai Zheyü, with existing shareholder Oriza Holdings significantly oversubscribing its portion. The newly acquired funds are earmarked for refining and deploying scenario-specific AI medical intelligent agents, as well as forging a scholarly communication platform between pharmaceutical firms and medical professionals. Weikai Capital has been appointed as the long-term exclusive financial advisor for this endeavor.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
